TerrAscend Corp.
TSX:TSND.TODrug Manufacturers - Specialty & Generic
-$0.02 today
- Market cap
- $193.65M
- Beta
- 2.04
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$0.26
Volume 0.26M
Average 0.31M
TSND.TO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
TerrAscend Corp.TSX: TSND.TO
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA grows, but more slowly than its trailing trend
Q1 FY2026 EBITDA of $15.78M rose 19.9% year over year, behind the +510.4% change in trailing-twelve-month EBITDA. Sequentially, it rose 6.8% from the prior quarter.
Context
- EBITDA amounted to 23.7% of revenue in FY2025, up 21.7 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $35.78M (-43.1%) for the fiscal year ending Dec 2026, a slowdown from the +922.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $15.78M+6.8% QoQ
- Last fiscal yearDec 2025
- $62.92M+922.2% YoY
- LTMMar 2026
- $60.46M+510.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +19.9% | -33.3% | -53.2 pp |
| 1 year | +922.2% | -43.1% | -965.3 pp |
| 3-year CAGR | — | -8.5% | — |
| 5-year CAGR | -1.5% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 62.92M USD
- Year-over-year change
- +922.2%
- 4-year CAGR
- +8.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 62.92M | +922.2% |
| FY2024 | 2024-12-31 | 6.16M | +699.9% |
| FY2023 | 2023-12-31 | (1.03M) | +99.6% |
| FY2022 | 2022-12-31 | (246.52M) | -648.3% |
| FY2021 | 2021-12-31 | 44.96M | — |
EBITDA vs competitors
How TSND.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +510.4% is the highest of 10, against a peer median of +21.8%.
- EBITDA amounts to 23.1% of revenue for TSND.TO, versus a peer median of 22.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $75.52M USD | -3.6% | +5.1% | 24.7% | |
| LTM Mar 2026 | $60.46M USD | +510.4% | — | 23.1% | |
| LTM Mar 2026 | CA$49.15M CAD | +45.8% | — | 31.0% | |
| LTM Mar 2026 | $25.12M USD | +96.0% | +26.0% | 49.3% | |
| LTM Mar 2026 | $17.79M USD | +21.8% | +0.0% | 31.9% | |
| LTM Mar 2026 | CA$9.82M CAD | -80.9% | — | 3.1% | |
| LTM Mar 2026 | -$5.36M USD | +48.2% | — | 10.5% | |
| LTM Mar 2026 | -CA$40.84M CAD | -681.4% | — | 14.9% | |
| LTM Mar 2026 | -$44.63M USD | -141.2% | — | — | |
| LTM Mar 2026 | -CA$63.48M CAD | +86.8% | — | 20.4% | |
| Peer median (excluding TSND.TO) | — | +21.8% | +5.1% | 22.6% | |
Competitors are the stored peer set for TSND.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 243.36M | 240.45M | 317.33M | 306.68M | 265.12M |
| Cost of Revenue | 109.32M | 203.35M | 112.49M | 156.72M | 131.93M |
| Gross Profit | 134.04M | 119.74M | 138.02M | 149.96M | 133.19M |
| Gross Margin | 55.1% | 49.8% | 43.5% | 48.9% | 50.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 73.71M | 116.64M | 112.17M | 111.33M | 82.41M |
| Operating Expenses | 94.12M | 150.69M | 179.56M | 167.07M | 87.78M |
| Depreciation & Amortization | 13.63M | 24.6M | 22.7M | 22.99M | 17.51M |
| EBITDA | 44.96M | (246.52M) | (1.03M) | 6.16M | 62.92M |
| EBITDA Margin | 18.5% | -102.5% | -0.3% | 2.0% | 23.7% |
| Operating Income | 31.33M | (23.04M) | (19.87M) | (17.11M) | 45.41M |
| Operating Margin | 12.9% | -9.6% | -6.3% | -5.6% | 17.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 24.57M | 37.9M | 35.11M | 35.4M | 36.93M |
| Other Income / Expenses | 12.46M | (277.92M) | (38.97M) | (35.13M) | (40.34M) |
| Income Before Tax | 43.78M | (300.95M) | (58.83M) | (52.23M) | 5.06M |
| Pre-Tax Margin | 18.0% | -125.2% | -18.5% | -17.0% | 1.9% |
| Income Tax Expense | 28.88M | (10.46M) | 23.45M | 20.44M | 29.98M |
| Net Income | 3.06M | (303.96M) | (91.1M) | (80.23M) | (87.74M) |
| Net Margin | 1.3% | -126.4% | -28.7% | -26.2% | -33.1% |
| EPS (Basic) | 0.07 | (1.31) | (0.32) | (0.28) | (0.29) |
| EPS (Diluted) | 0.01 | (1.31) | (0.32) | (0.28) | (0.29) |
| Weighted Avg Shares | 181.06M | 244.35M | 279.29M | 291.51M | 301.08M |
| Weighted Avg Shares (Diluted) | 208.71M | 244.35M | 279.29M | 291.51M | 301.08M |
TerrAscend Corp.
TSX:TSND.TO
Intrinsic Alpha fair value
Locked
Current Price
$0.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.